Viewing Study NCT06663059


Ignite Creation Date: 2025-12-24 @ 2:30 PM
Ignite Modification Date: 2026-01-28 @ 4:16 PM
Study NCT ID: NCT06663059
Status: RECRUITING
Last Update Posted: 2024-10-29
First Post: 2024-08-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study
Sponsor:
Organization: